301 related articles for article (PubMed ID: 12951565)
1. The role of alpha-synuclein in Parkinson's disease: insights from animal models.
Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K
Nat Rev Neurosci; 2003 Sep; 4(9):727-38. PubMed ID: 12951565
[No Abstract] [Full Text] [Related]
2. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A; Wersinger C; Vernier P
FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
[TBL] [Abstract][Full Text] [Related]
3. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
4. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
Volles MJ; Lansbury PT
Biochemistry; 2003 Jul; 42(26):7871-8. PubMed ID: 12834338
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein in Parkinson's disease: light from two new angles.
Golbe LI; Mouradian MM
Ann Neurol; 2004 Feb; 55(2):153-6. PubMed ID: 14755715
[No Abstract] [Full Text] [Related]
7. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
Kim S; Seo JH; Suh YH
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
[TBL] [Abstract][Full Text] [Related]
8. Experimental models of Parkinson's disease.
Beal MF
Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
[TBL] [Abstract][Full Text] [Related]
9. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
[No Abstract] [Full Text] [Related]
10. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
Lotharius J; Brundin P
Nat Rev Neurosci; 2002 Dec; 3(12):932-42. PubMed ID: 12461550
[No Abstract] [Full Text] [Related]
11. Synucleins and their relationship to Parkinson's disease.
von Bohlen Und Halbach O
Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein: normal function and role in neurodegenerative diseases.
Norris EH; Giasson BI; Lee VM
Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
[TBL] [Abstract][Full Text] [Related]
14. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
[No Abstract] [Full Text] [Related]
15. [alpha-Synuclein and familial Parkinson's disease].
Iwatsubo T
No To Shinkei; 1999 Jun; 51(6):481-6. PubMed ID: 10423749
[No Abstract] [Full Text] [Related]
16. alpha-Synuclein locus triplication causes Parkinson's disease.
Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
[No Abstract] [Full Text] [Related]
17. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
18. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
20. Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.
Stefanis L; Wang Q; Oo T; Lang-Rollin I; Burke RE; Dauer WT
Eur J Neurosci; 2004 Oct; 20(7):1969-72. PubMed ID: 15380020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
